Skip to main content
Research
  1. Queen Mary University of London
  2. Research
  3. Publications

Publications: Prof Ranjit Manchanda

Back to Search
Fierheller C, Sarig K, Oxley S, Kalra A, Sobocan M, Sideris M, Gootzen T, Ferris M et al. ( 2024 ) . BRCA awareness and testing experience in the UK Jewish population: A qualitative study . Gynecologic Oncology . vol. 190 , s162 - s163 .
Fierheller C, Gootzen T, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A et al. ( 2024 ) . BRCA1 and BRCA2 information provision online: An occasion for improvement . Gynecologic Oncology . vol. 190 ,
Manchanda R, Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J et al. ( 2024 ) . Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer . Gynecologic Oncology . vol. 190 , s159 - s160 .
Fierheller C, Sun L, Wei X, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al. ( 2024 ) . Population-based BRCA1 and BRCA2 genetic testing is cost-effective in Canada . Gynecologic Oncology . vol. 190 ,
Bizzarri N, Querleu D, Ramirez PT, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Salehi S et al. ( 2024 ) . Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study . European Journal of Cancer vol. 211 , Article 114310 , 114310 - 114310 .
Ng ZY, Manchanda R, Cibula D ( 2024 ) . The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study . Gynecologic Oncology
Torr B, Jones C, Kavanaugh G, Hamill M, Allen S, Choi S, Garrett A, Valganon-Petrizan M et al. ( 2024 ) . BRCA-DIRECT digital pathway for diagnostic germline genetic testing within a UK breast oncology setting: a randomised, non-inferiority trial . British Journal of Cancer vol. 131 , ( 9 ) 1506 - 1515 .
Sundar S, Agarwal R, Davenport C, Scandrett K, Johnson S, Sengupta P, Selvi-Vikram R, Kwong FL et al. ( 2024 ) . Risk-prediction models in postmenopausal patients with symptoms of suspected ovarian cancer in the UK (ROCkeTS): a multicentre, prospective diagnostic accuracy study . The Lancet Oncology vol. 25 , ( 10 ) 1371 - 1386 .
Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al. ( 2024 ) . Economic Evaluation of Population-Based <i>BRCA1</i> and <i>BRCA2</i> Testing in Canada . JAMA Network Open vol. 7 , ( 9 ) e2432725 - e2432725 .
Leung EY, Nicum S, Morrison J, Brenton JD, Funingana I-G, Morgan RD, Ghaem-Maghami S, Miles T et al. ( 2024 ) . British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom . International Journal of Gynecological Cancer vol. 34 , ( 9 ) 1334 - 1343 .
Moss E, Taylor A, Andreou A, Ang C, Arora R, Attygalle A, Banerjee S, Bowen R et al. ( 2024 ) . British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024 . European Journal of Obstetrics &amp; Gynecology and Reproductive Biology vol. 300 , 69 - 123 .
Oxley S, Ahmed S, Baxter K, Blake D, Braden V, Brincat MR, Bryan S, Dilley J et al. ( 2024 ) . Venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer . Int J Gynecol Cancer
Kwong FLA, Kristunas C, Davenport C, Deeks J, Mallett S, Agarwal R, Kehoe S, Timmerman D et al. ( 2024 ) . Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer . International Journal of Gynecological Cancer
Negri S, Fisch C, de Hullu JA, van Bommel M, Simons M, Bogaerts J, focusgroup CS, Hermens RPMG et al. ( 2024 ) . Diagnosis and management of isolated serous tubal intraepithelial carcinoma: A qualitative focus group study . BJOG An International Journal of Obstetrics & Gynaecology
Gootzen TA, Kalra A, Sarig K, Sobočan M, Oxley SG, Dworschak N, Georgiannakis A, Glynou S et al. ( 2024 ) . Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis . Cancers vol. 16 , ( 13 )
Sarig K, Oxley S, Kalra A, Sobocan M, Fierheller CT, Sideris M, Gootzen T, Ferris M et al. ( 2024 ) . BRCA awareness and testing experience in the UK Jewish population: a qualitative study . J Med Genet vol. 61 , ( 7 ) 716 - 725 .
Manchanda R, Sun L, Sobocan M, Rodriguez IV, Wei X, Kalra A, Oxley S, Sideris M et al. ( 2024 ) . Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian Cancer . Journal of the National Comprehensive Cancer Network vol. 22 , ( 2D )
Joy JD, Malacrida B, Laforêts F, Kotantaki P, Maniati E, Manchanda R, Annibaldi A, Hopkins S et al. ( 2024 ) . Human 3D Ovarian Cancer Models Reveal Malignant Cell–Intrinsic and –Extrinsic Factors That Influence CAR T-cell Activity . Cancer Research vol. 84 , ( 15 ) 2432 - 2449 .
Slade E, Berg L, Dworzynski K, Manchanda R ( 2024 ) . Ovarian cancer: identifying and managing familial and genetic risk—summary of new NICE guidance . The BMJ vol. 385 ,
Newton C, Graham R, Liberale V, Burnell M, Menon U, Mould T, Olaitan A, Macdonald N et al. ( 2024 ) . Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer . Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 44 , ( 1 )
Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Fierheller C, Kalra A, Sia J, Miller RE et al. ( 2024 ) . Patient decision aids in mainstreaming genetic testing for women with ovarian cancer: A prospective cohort study . BJOG vol. 131 , ( 6 ) 848 - 857 .
Kwong FL, Kristunas C, Davenport C, Aggarwal R, Deeks J, Mallett S, Kehoe S, Timmerman D et al. ( 2024 ) . Investigating harms of testing for ovarian cancer – psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study . BJOG An International Journal of Obstetrics & Gynaecology vol. 131 , ( 10 ) 1400 - 1410 .
Oxley SG, Wei X, Sideris M, Blyuss O, Kalra A, Sia JJY, Ganesan S, Fierheller CT et al. ( 2024 ) . Utility Scores for Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy: Mapping to EQ-5D . Cancers vol. 16 , ( 7 ) 1358 - 1358 .
Elorbany S, Berlato C, Carnevalli L, Barry S, Maniati E, Wang J, Manchanda R, Kzhyshkowska J et al. ( 2024 ) . Abstract 6553: Targeting macrophages and regulatory T cells improves response to chemotherapy in high-grade serous ovarian cancer . Cancer Research vol. 84 , ( 6_Supplement ) 6553 - 6553 .
Manchanda R, Evans DG, Antoniou AC, Brentnall A ( 2024 ) . Penetrance estimates of hereditary cancers in a population setting using UK Biobank data . BJC Reports vol. 2 , ( 1 )
Sideris M, Brincat MR, Blyuss O, Enumula M, Cyclewala S, Oxley S, Sia J, Kalra A et al. ( 2024 ) . 1033 Validation of P-POSSUM scale in ovarian cancer (OC) cytoreductive surgery . Conference: Poster and E-Postersa391.3 - a3a392 .
Gootzen TA, Kalra A, Sarig K, Sobocan M, Oxley S, Dworschak N, Georgiannakis A, Glynou S et al. ( 2024 ) . 405 Analysis of BRCA1 and BRCA2 information provision online . Conference: Poster and E-Postersa448 - a449 .
Sun L, Wei X, Fierheller CT, Dawson L, Oxley S, Kalra A, Sia J, Feldman F et al. ( 2024 ) . 406 Population-based BRCA1 and BRCA2 testing in Canada: an economic evaluation . Conference: Young Investigator Sessiona52 - a53 .
Wei X, Sun L, Slade E, Fierheller C, Oxley S, Kalra A, Sia J, Sideris M et al. ( 2024 ) . 443 Cost-effectiveness analysis of cancer susceptibility gene-specific prevention strategies for ovarian and breast cancer . Conference: Oral Sessionsa40 - a41 .
Kalra A, Gootzen TA, Fierheller CT, Sarig K, Pan Y, Parmar A, Papalois K-B, Samuels AJ et al. ( 2024 ) . 461 HBOC and lynch syndrome: ai-powered multi-platform analysis of social media activity . Conference: Poster and E-Postersa259.1 - a2a259 .
Oxley S, Sia J, Samuels A, Kalra A, Wei X, Fierheller CT, Sideris M, Glenn Mccluggage W et al. ( 2024 ) . 583 Experiences of women following risk-reducing early-salpingectomy and delayed-oophorectomy and salpingo-oophorectomy on the PROTECTOR trial: a qualitative study . Conference: Poster and E-Postersa454.1 - a4a454 .
Oxley S, Wei X, Sideris M, Blyuss O, Kalra A, Sia J, Ganesan S, Fierheller CT et al. ( 2024 ) . 948 EQ-5D utility scores for risk-reducing mastectomy and risk-reducing salpingo-oophorectomy: mapping from SF-12 and SF-36 . Conference: Poster and E-Postersa460.1 - a4a460 .
Joy JD, Malacrida B, Laforets F, Kotantaki P, Maniati E, Manchanda R, Hopkins S, Garrobo-Calleja I et al. ( 2024 ) . Abstract B079: Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR-T cell activity . Cancer Research vol. 84 , ( 5_Supplement_2 ) b079 - b079 .
Malacrida B, Elorbany S, Maniati E, Bryan-Ravenscroft R, Skingsley SLP, Laforets F, Manchanda R, Balkwill FR ( 2024 ) . Abstract PR-009: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer using human multicellular in vitro models . Cancer Research vol. 84 , ( 5_Supplement_2 )
Sideris M, Menon U, Manchanda R ( 2024 ) . Screening and prevention of ovarian cancer . The Medical Journal of Australia vol. 220 , ( 5 ) 264 - 274 .
Wei X, Sun L, Slade E, Fierheller CT, Oxley S, Kalra A, Sia J, Sideris M et al. ( 2024 ) . Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer . JAMA network open vol. 7 , ( 2 )
Lakhiani A, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al. ( 2023 ) . Analysis of Anxiety, Depression and Fear of Progression at 12 Months Post-Cytoreductive Surgery in the SOCQER-2 (Surgery in Ovarian Cancer—Quality of Life Evaluation Research) Prospective, International, Multicentre Study . Cancers vol. 16 , ( 1 )
Wei X, Sun L, Slade E, Oxley S, Kalra A, Sia J, Sideris M, Fierheller C et al. ( 2023 ) . EE675 Cost-Effectiveness Analysis of Cancer Susceptibility Gene-Specific Prevention and Surveillance Strategies for Ovarian and Breast Cancer . Value in Health . vol. 26 , s183 - s184 .
Dilley J, Gentry-Maharaj A, Ryan A, Burnell M, Manchanda R, Kalsi J, Singh N, Woolas R et al. ( 2023 ) . Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) . Gynecol Oncol vol. 179 , 123 - 130 .
Gaba F, Blyuss O, Chandrasekaran D, Bizzarri N, Refky B, Barton D, Ind T, Nobbenhuis M et al. ( 2023 ) . Prognosis Following Surgery for Recurrent Ovarian Cancer and Diagnostic Criteria Predictive of Cytoreduction Success: A Systematic Review and Meta-Analysis . Diagnostics vol. 13 , ( 22 )
Lacaze P, Marquina C, Tiller J, Brotchie A, Kang Y-J, Merritt MA, Green RC, Watts GF et al. ( 2023 ) . Combined population genomic screening for three high-risk conditions in Australia: a modelling study . EClinicalMedicine vol. 66 ,
Torr B, Choi S, Allen S, Hamill M, Kavanaugh G, MacMahon S, Poyastro-Pearson E, Yuan L et al. ( 2023 ) . LBA101 BRCA-DIRECT: A randomised UK study evaluating a digital pathway for germline genetic testing and non-inferiority of digitally-delivered information in women with breast cancer . Annals of Oncology vol. 34 ,
Wei X, Oxley S, Sideris M, Legood R, Manchanda R ( 2023 ) . Patient-reported quality of life following prophylactic surgery for breast and ovarian cancer prevention: response . American Journal of Obstetrics and Gynecology vol. 230 , ( 2 ) 274 - 275 .
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Singh N, Manchanda R, Kalsi JK, Woolas R et al. ( 2023 ) . Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial . The Lancet Oncology vol. 24 , ( 9 ) 1018 - 1028 .
Bizzarri N, Querleu D, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Salehi S, Ayhan A et al. ( 2023 ) . Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study . American Journal of Obstetrics and Gynecology vol. 229 , ( 4 ) 428.e1 - 428.e12 .
Pillai D, Narayan J, Gentry-Maharaj A, Deo S, Vijaykumar DK, Mukherjee P, Wadhwa N, Bhasin A et al. ( 2023 ) . Co-Creation of Breast Cancer Risk Communication Tools and an Assessment of Risk Factor Awareness: A Qualitative Study of Patients and the Public in India . Cancers vol. 15 , ( 11 )
Morgan RD, Clamp AR, Barnes BM, Timms K, Schlecht H, Yarram-Smith L, Wallis Y, Valganon-Petrizan M et al. ( 2023 ) . Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study . International Journal of Gynecological Cancer vol. 33 , ( 8 ) 1253 - 1259 .
Elorbany S, Berlato C, Carnevalli L, Maniati E, Wang J, Barry S, Manchanda R, Kzhyshkowska J et al. ( 2023 ) . Abstract LB195: Immunotherapies that repolarize macrophages and CD4 T cells enhance the effect of chemotherapy in high-grade serous ovarian cancer . Cancer Research vol. 83 , ( 8_Supplement ) lb195 - lb195 .
Wei X, Oxley S, Sideris M, Kalra A, Brentnall A, Sun L, Yang L, Legood R et al. ( 2023 ) . Quality of life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis . American Journal of Obstetrics and Gynecology vol. 229 , ( 4 ) 388 - 409.e4 .
Malacrida B, Elorbany S, Maniati E, Laforets F, Manchanda R, Balkwill FR ( 2023 ) . Abstract 4551: Reconstructing the metastatic tumor microenvironment of high grade serous ovarian cancer: understanding the contribution of malignant cells . Cancer Research vol. 83 , ( 7_Supplement ) 4551 - 4551 .
Laforets F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F ( 2023 ) . Abstract 5913: Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments . Cancer Research vol. 83 , ( 7_Supplement ) 5913 - 5913 .
Kotantaki P, Laforêts F, Maniati E, Berlato C, Malliouri A, Devlin MJ, Malacrida B, Elorbany S et al. ( 2023 ) . Abstract 5957: Chemotherapy-induced extracellular matrix remodeling in HGSOC . Cancer Research vol. 83 , ( 7_Supplement ) 5957 - 5957 .
Laforêts F, Kotantaki P, Malacrida B, Elorbany S, Manchanda R, Donnadieu E, Balkwill F ( 2023 ) . Semi-supervised analysis of myeloid and T cell behavior in ex vivo ovarian tumor slices reveals changes in cell motility after treatments . iScience vol. 26 , ( 4 )
Gaba F, Blyuss O, Tan A, Munblit D, Oxley S, Khan K, Legood R, Manchanda R ( 2023 ) . Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis . Cancers vol. 15 , ( 5 )
Oxley S, Wei X, Sideris M, Manchanda R ( 2023 ) . Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer . Screening and Risk Reduction Strategies for Breast Cancer , Springer Nature
Oxley S, Kalra A, Sideris M, Itzkowitz N, Evans O, Atakpa EC, Brentnall AR, Dworschak N et al. ( 2023 ) . Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK . Cancers vol. 15 , ( 4 )
Lacaze P, Manchanda R, Green RC ( 2023 ) . Prioritizing the detection of rare pathogenic variants in population screening . Nature Reviews Genetics vol. 24 , ( 4 ) 205 - 206 .
Wei X, Oxley S, Sideris M, Kalra A, Sun L, Yang L, Legood R, Manchanda R ( 2022 ) . Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review . Cancers vol. 14 , ( 24 )
Yong N, Cooper N, Yorke S, Baran C, Khan K, Tan A, Sideris M, Iliodromiti S et al. ( 2022 ) . Variation in outcome reporting in studies of fertility‐sparing surgery for cervical cancer: A systematic review . BJOG An International Journal of Obstetrics & Gynaecology vol. 130 , ( 2 ) 163 - 175 .
Grube M, Neilson A, Plante M, Brummel K, Kroon CD, Schochter F, Sideris M, Heitz F et al. ( 2022 ) . O031/#777 Lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease: results from the leopard trial . Conference: Focused Plenary Abstractsa20.1 - a2a20 .
Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A, Falconer H, Querleu D, Ayhan A et al. ( 2022 ) . Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy . Obstetrics and Gynecology vol. 141 , ( 1 ) 207 - 214 .
Oxley S, Xiong R, Wei X, Kalra A, Sideris M, Legood R, Manchanda R ( 2022 ) . Quality of Life after Risk-Reducing Hysterectomy for Endometrial Cancer Prevention: A Systematic Review . Cancers vol. 14 , ( 23 )
Hanson H, Kulkarni A, Loong L, Kavanaugh G, Torr B, Allen S, Ahmed M, Antoniou AC et al. ( 2022 ) . UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2 . Journal of Medical Genetics vol. 60 , ( 5 ) 417 - 429 .
Gaba F, Ash K, Blyuss O, Bizzarri N, Kamfwa P, Ramirez PT, Kotsopoulos IC, Chandrasekaran D et al. ( 2022 ) . Patient outcomes following interval and delayed cytoreductive surgery in advanced ovarian cancer: protocol for a multicenter, international, cohort study (Global Gynaecological Oncology Surgical Outcomes Collaborative) . International Journal of Gynecologic Cancer vol. 32 , ( 12 ) 1606 - 1610 .
Philpott S, Raikou M, Manchanda R, Lockley M, Singh N, Scott M, Evans DG, Adlard J et al. ( 2022 ) . The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants in BRCA1 and BRCA2 . Journal of Medical Genetics vol. 60 , ( 5 ) 440 - 449 .
Wei X, Oxley S, Sideris M, Kalra A, Legood R, Manchanda R ( 2022 ) . 2022-RA-1270-ESGO Quality of Life after risk-reducing surgery for breast and ovarian cancer prevention: a systematic review and meta-analysis . Conference: Prevention of gynaecologic cancera383.1 - a3a383 .
Wei X, Oxley S, Sideris M, Kalra A, Legood R, Manchanda R ( 2022 ) . 2022-RA-1272-ESGO Cost-effectiveness of risk-reducing surgery for breast and ovarian cancer prevention: a systematic review . Conference: Prevention of gynaecologic cancera383.2 - a3a384 .
Bizzarri N, Dostálek L, Lonkhuijzen LR, Giannarelli D, Lopez A, Falconer H, Querleu D, Ayhan A et al. ( 2022 ) . 2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study . Conference: Cervical cancera52.2 - a5a53 .
Gaba F, Blyuss O, Tan A, Chandrasekaran D, Munblit D, Legood R, Khan K, Manchanda R ( 2022 ) . 2022-RA-1390-ESGO Meta-analysis of breast cancer risk and breast cancer specific mortality following risk reducing salpingo-oophorectomy in BRCA carriers . Conference: Prevention of gynaecologic cancera385.1 - a3a385 .
Yong N, Cooper N, Yorke S, Baran C, Khan K, Tan A, Sideris M, Iliodromiti S et al. ( 2022 ) . 2022-RA-1407-ESGO Variation in outcome reporting in studies of fertility sparing surgery for cervical cancer: a systematic review . Conference: Fertility/Pregnancya179.2 - a1a180 .
Sobocan M, Chandrasekaran D, Sideris M, Blyuss O, Miller R, Mills-Baldock T, Crusz S, Sun L et al. ( 2022 ) . 2022-RA-1443-ESGO Patient decision aids in genetic testing for women with ovarian cancer . Conference: Vaginal and vulvar cancera463.1 - a4a463 .
Burnell M, Gaba F, Sideris M, Sobocan M, Rakshit R, Sanderson S, Loggenberg K, Gessler S et al. ( 2022 ) . 2022-RA-1465-ESGO Randomised trial of population based BRCA testing in Ashkenazi Jews: long term secondary lifestyle behavioural outcomes . Conference: Quality of life after treatmenta402.1 - a4a402 .
Cummins C, Kumar S, Long J, Balega J, Broadhead T, Duncan T, Edmondson RJ, Fotopoulou C et al. ( 2022 ) . Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study . Cancers vol. 14 , ( 18 )
Van der Kolk WL, Van der Zee AGJ, Slomovitz BM, Baldwin PJW, Van Doorn HC, De Hullu JA, Van der Velden J, Gaarenstroom KN et al. ( 2022 ) . Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe . Gynecologic Oncology vol. 167 , ( 1 ) 3 - 10 .
Sun L, Wei X, Manchanda R, Legood R, Yang L ( 2022 ) . Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control . China CDC Wkly
Manchanda R, Sideris M ( 2022 ) . Population based genetic testing for cancer susceptibility genes: quo vadis . BJOG: An International Journal of Obstetrics &amp; Gynaecology
Torr B, Jones C, Choi S, Allen S, Kavanaugh G, Hamill M, Garrett A, MacMahon S et al. ( 2022 ) . A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot . Journal of Medical Genetics vol. 59 , ( 12 ) 1179 - 1188 .
Burnell M, Gaba F, Sobocan M, Desai R, Sanderson S, Loggenberg K, Gessler S, Side L et al. ( 2022 ) . Randomised trial of population based BRCA testing in Ashkenazi Jews: Long term secondary lifestyle behavioural outcomes . BJOG: An International Journal of Obstetrics &amp; Gynaecology
Tindale LC, Zhantuyakova A, Lam S, Woo M, Kwon JS, Hanley GE, Knoppers B, Schrader KA et al. ( 2022 ) . Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention . Current Oncology vol. 29 , ( 7 ) 4632 - 4646 .
Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera K, Kristiansen M, Leavy OC et al. ( 2022 ) . The DNA methylome of cervical cells can predict the presence of ovarian cancer . Nature Communications vol. 13 , ( 1 )
Kalra A, Sobocan M, Reisel D, Manchanda R ( 2022 ) . Role of Genetics in Gynaecological Cancers . Gynecological Oncology , Springer Nature
Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, Antoniou A, Side L et al. ( 2022 ) . Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews . Diagnostics vol. 12 , ( 5 )
Sun L, Cui B, Wei X, Sadique Z, Yang L, Manchanda R, Legood R ( 2022 ) . Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China . Cancers vol. 14 , ( 7 )
Taylor A, Sundar SS, Bowen R, Clayton R, Coleridge S, Fotopoulou C, Ghaem-Maghami S, Ledermann J et al. ( 2022 ) . British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic . Obstetrical & Gynecological Survey vol. 77 , ( 3 ) 156 - 157 .
Manchanda R ( 2022 ) . Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer . Editors: Manchanda, R , MDPI
Sundar S, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al. ( 2022 ) . Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study . BJOG An International Journal of Obstetrics & Gynaecology vol. 129 , ( 7 ) 1122 - 1132 .
Manchanda R ( 2022 ) . Special Issue “Gynaecological Cancers Risk: Breast Cancer, Ovarian Cancer and Endometrial Cancer” . Cancers vol. 14 , ( 2 )
Kriplani D, Olivar AA, Tchrakian N, Butcher D, Casey L, Crook JA, Deo N, Dilley J et al. ( 2022 ) . Concise Reporting of Benign Endometrial Biopsies is an Acceptable Alternative to Descriptive Reporting . Int J Gynecol Pathol vol. 41 , ( 1 ) 20 - 27 .
Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Scambia G, Ayhan A et al. ( 2021 ) . Post-recurrence survival in patients with cervical cancer . Gynecologic Oncology vol. 164 , ( 2 ) 362 - 369 .
( 2021 ) . Correction: xBritish Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom . International Journal of Gynecological Cancer vol. 31 , ( 12 ) 1619 - 1619 .
Lee A, Yang X, Tyrer J, Gentry-Maharaj A, Ryan A, Mavaddat N, Cunningham AP, Carver T et al. ( 2021 ) . Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors . Journal of Medical Genetics vol. 59 , ( 7 ) 632 - 643 .
Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R, Sanderson S, Brady A et al. ( 2021 ) . Jewish cultural and religious factors and uptake of population‐based BRCA testing across denominations: a cohort study . BJOG An International Journal of Obstetrics & Gynaecology vol. 129 , ( 6 ) 959 - 968 .
Taylor A, Sundar SS, Bowen R, Clayton R, Coleridge S, Fotopoulou C, Ghaem-Maghami S, Ledermann J et al. ( 2021 ) . British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic . International Journal of Gynecological Cancer vol. 32 , ( 1 ) 9 - 14 .
Philpott S, Raikou M, Manchanda R, Evans G, Edmondson R, Menon U, Ahmed M, Woodward E et al. ( 2021 ) . 423 Results of the avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance program for BRCA mutation-carriers . International Journal of Gynecological Cancer vol. 31 , ( Suppl 3 ) a373 - a374 .
Manchanda R, Oxley S, Ghaem-Maghami S, Sundar S ( 2021 ) . COVID-19 and the impact on gynecologic cancer care . International Journal of Gynecology and Obstetrics
Manchanda R, Gaba F, Talaulikar V, Pundir J, Gessler S, Davies M, Menon U, College of Obstetricians and Gynaecologists OBOTR ( 2021 ) . Risk‐Reducing Salpingo‐Oophorectomy and the Use of Hormone Replacement Therapy Below the Age of Natural Menopause . BJOG An International Journal of Obstetrics & Gynaecology vol. 129 , ( 1 ) e16 - e34 .
Taylor J, Burnell M, Ryan A, Karpinskyj C, Kalsi J, Taylor H, Apostolidou S, Sharma A et al. ( 2021 ) . Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS . BJOG An International Journal of Obstetrics & Gynaecology vol. 129 , ( 1 ) 110 - 118 .
Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Fagotti A, Manchanda R et al. ( 2021 ) . The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer . European Journal of Cancer vol. 158 , 111 - 122 .
Sundar S, Cummins C, Balega J, Broadhead T, Duncan T, Edmondson R, Fotopoulou C, Kolomainen D et al. ( 2021 ) . 718 Investigating impact of ultra-radical surgery in advanced ovarian cancer using population level data linked to the SOCQER 2 multicentre study . Conference: Ovarian cancera264 - a265 .
Reisel D, Burnell M, Side L, Loggenberg K, Gessler S, Desai R, Sanderson S, Brady A et al. ( 2021 ) . 874 Uptake of population based BRCA-testing across Jewish denominations and affect of cultural and religious factors: a cohort study . International Journal of Gynecological Cancer . Conference: Prevention of gynaecologic cancer vol. 31 , a316 - a316 .
Van Lonkhuijzen L, Dostalek L, Jarkovsky J, Lopez A, Falconer H, Scambia G, Ayhan A, Kim S et al. ( 2021 ) . 942 Survival after recurrence in early-stage cervical cancer patients . International Journal of Gynecological Cancer . Conference: Cervical cancer vol. 31 , a53 - a55 .
Cibula D, Jarkovsky J, Van Lonkhuijzen L, Falconer H, Fagotti A, Ayhan A, Kim S, Ortiz DI et al. ( 2021 ) . 960 The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients . International Journal of Gynecological Cancer . Conference: Cervical cancer vol. 31 , a57 - a59 .
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan Y, Saiz A, Razumova Z, Zalewski K et al. ( 2021 ) . 984 Impact of SARS-CoV-2 on training and mental wellbeing of surgical gynaecological oncology trainees . International Journal of Gynecological Cancer . Conference: Miscellaneous vol. 31 , a169 - a169 .
Rockall AG, Barwick TD, Wilson W, Singh N, Bharwani N, Sohaib A, Nobbenhuis M, Warbey V et al. ( 2021 ) . DIAGNOSTIC ACCURACY OF FEC-PET/CT, FDG-PET/CT AND DIFFUSION-WEIGHTED MRI IN DETECTION OF NODAL METASTASES IN SURGICALLY TREATED ENDOMETRIAL AND CERVICAL CARCINOMA . Clinical Cancer Researchclincanres.1834.2021 - clincanres.1834.2021 .
Gaba F, Blyuss O, Rodriguez I, Dilley J, Wan Y-LL, Saiz A, Razumova Z, Zalewski K et al. ( 2021 ) . Impact of SARS-CoV-2 on training and mental well-being of surgical gynecological oncology trainees . Int J Gynecol Cancer vol. 31 , ( 9 ) 1268 - 1277 .
Chandrasekaran D, Sobocan M, Blyuss O, Miller RE, Evans O, Crusz SM, Mills-Baldock T, Sun L et al. ( 2021 ) . Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: Signpost study . Cancers vol. 13 , ( 17 )
Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J et al. ( 2021 ) . Ovarian Cancer Population Screening and Mortality After Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial . Obstetrical & Gynecological Survey vol. 76 , ( 9 ) 537 - 538 .
Reisel D, Baran C, Manchanda R ( 2021 ) . Preventive population genomics- the model of BRCA related cancers . Advances in Genetics
Oonk MH, Slomovitz B, Baldwin P, Vergote I, Sharma A, Manchanda R ( 2021 ) . Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II . Journal of Clinical Oncology
Mariño IP, Vázquez MA, Blyuss O, Ryan A, Gentry-Maharaj A, Kalsi J, Manchanda R, Jacobs I et al. ( 2021 ) . Computational learning methods for early detection of ovarian cancer . Conference: Emerging Topics in Artificial Intelligence (ETAI) 2021
Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J et al. ( 2021 ) . Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial . The Lancet vol. 397 , ( 10290 ) 2182 - 2193 .
Gaba F, Goyal S, Marks D, Chandrasekaran D, Evans O, Robbani S, Tyson C, Legood R et al. ( 2021 ) . Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study . Journal of Medical Genetics vol. 59 , ( 2 ) 122 - 132 .
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al. ( 2021 ) . Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” Gynecol. Oncol. 154 (2019) 441–448 . Gynecologic Oncology vol. 161 , ( 1 ) 328 - 329 .
Sundar S, Manchanda R, Gourley C, George A, Wallace A, Balega J, Williams S, Wallis Y et al. ( 2021 ) . British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom . Int J Gynecol Cancer vol. 31 , ( 2 ) 272 - 278 .
Phadnis S, Selek S, Farrag A, Zachou G, Chandrasekaran D, Brockbank E, Lawrence A, Manchanda R et al. ( 2021 ) . Cytoreduction surgery for recurrent ovarian cancer: cohort study from UK tertiary centre . BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY . vol. 128 , 58 - 59 .
Gaba F, Blyuss O, Sanderson S, Antoniou A, Kalsi J, Wallace A, Menon U, Legood R et al. ( 2020 ) . 401 Population testing and personalised ovarian cancer risk prediction for risk adapted targeted prevention . Conference: Prevention of gynaecologic cancera93.1 - a9a93 .
Gaba F, Blyuss O, Legood R, Izatt L, Tripathi V, Ragupathy K, Crawfordd R, Evans DG et al. ( 2020 ) . 505 Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study . International Journal of Gynecological Cancer . Conference: Prevention of gynaecologic cancer vol. 30 , a93 - a94 .
Gaba F, Marks D, Saridogan E, Mccluggage WG, Hanson H, Singh N, Legood R, Evans DG et al. ( 2020 ) . 507 Surgical decision making in premenopausal brca carriers considering risk reducing early-salpingectomy or salpingo-oophorectomy: a qualitative study . International Journal of Gynecological Cancer . Conference: Prevention of gynaecologic cancer vol. 30 , a94 - a94 .
Gallagher A, Waller J, Manchanda R, Jacobs I, Sanderson S ( 2020 ) . Women’s Intentions to Engage in Risk-Reducing Behaviours after Receiving Personal Ovarian Cancer Risk Information: An Experimental Survey Study . Cancers vol. 12 , ( 12 )
Krämer P, Grube M, Renno T, Brar H, McAlpine J, de Kroon C, Heitz F, Heublein S et al. ( 2020 ) . 454 Study in progress: international retrospective study on lymphadenectomy in endometrioid ovarian carcinoma patients with early stage disease (LEOPARD) . Conference: Postera188.2 - a1a189 .
Krämer P, Talhouk A, Brett MA, Chiu DS, Cairns ES, Scheunhage DA, Hammond RFL, Farnell D et al. ( 2020 ) . Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma . Clinical Cancer Research vol. 26 , ( 20 ) 5400 - 5410 .
Grube M, Krämer P, Chiu D, Bosse T, Scheunhage D, Koebel M, Singh N, Manchanda R et al. ( 2020 ) . Immunhistochemische Expression von L1CAM in endometrioiden Ovarialkarzinomen – Ein neuer prognostischer Marker? . Geburtshilfe und Frauenheilkunde . Conference: Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) vol. 80 ,
Gaba F, Robbani S, Singh N, McCluggage WG, Wilkinson N, Ganesan R, Bryson G, Rowlands G et al. ( 2020 ) . Preventing Ovarian Cancer through early Excision of Tubes and late Ovarian Removal (PROTECTOR): protocol for a prospective non-randomised multi-center trial . International Journal of Gynecological Cancer vol. 31 , ( 2 ) 286 - 291 .
Gaba F, Blyuss O, Chandrasekaran D, Osman M, Goyal S, Gan C, Izatt L, Tripathi V et al. ( 2020 ) . Attitudes towards risk‐reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study . BJOG An International Journal of Obstetrics & Gynaecology vol. 128 , ( 4 ) 714 - 726 .
Evans O, Manchanda R ( 2020 ) . Population-based Genetic Testing for Precision Prevention . Cancer Prevention Research vol. 13 , ( 8 ) 643 - 648 .
Manchanda R, Sun L, Patel S, Evans O, Wilschut J, De Freitas Lopes AC, Gaba F, Brentnall A et al. ( 2020 ) . Economic Evaluation of Population-Based BRCA1/BRCA2 Mutation Testing across Multiple Countries and Health Systems . Cancers vol. 12 , ( 7 )
Gentry-Maharaj A, Blyuss O, Ryan A, Burnell M, Karpinskyj C, Gunu R, Kalsi JK, Dawnay A et al. ( 2020 ) . Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women . Cancers vol. 12 , ( 7 )
Gaba F, Blyuss O, Liu X, Goyal S, Lahoti N, Chandrasekaran D, Kurzer M, Kalsi J et al. ( 2020 ) . Population study of ovarian cancer risk prediction for targeted screening and prevention . Cancers vol. 12 , ( 5 )
Manchanda R, Buist DSM, Evans DGR ( 2020 ) . Future Research Suggestions for Multigene Testing in Unselected Populations—Reply . JAMA Oncology vol. 6 , ( 5 ) 785 - 786 .
Manchanda R, Lieberman S, Gaba F, Lahad A, Levy-Lahad E ( 2020 ) . Population Screening for Inherited Predisposition to Breast and Ovarian Cancer . Annual Review of Genomics and Human Genetics vol. 21 , ( 1 ) 1 - 40 .
Manchanda R ( 2020 ) . Advances in the screening and prevention of Women's cancers . Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 65 , 1 - 2 .
Evans O, Gaba F, Manchanda R ( 2020 ) . Population-based genetic testing for Women's cancer prevention . Best Practice & Research Clinical Obstetrics & Gynaecology vol. 65 , 139 - 153 .
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al. ( 2020 ) . Corrigendum to “Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data” [Gynecol. Oncol. 154 (2019) 441–448] . Gynecologic Oncology vol. 157 , ( 2 ) 558 - 559 .
Gaba F, Manchanda R ( 2020 ) . Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers . Best Practice and Research: Clinical Obstetrics and Gynaecology vol. 65 , 46 - 65 .
Casey L, Powell A, Bohm S, Manchanda R, Lockley M, Kobel M, Singh N ( 2020 ) . Role of Ki67 Proliferation Index and CD8 Tumour-Infitrating Lymphocyte Counts in Predicting Outcome in High-Grade Serous Tubo-Ovarian Carcinoma (HGSC) Showing No/Partial Response to Neoadjuvant Chemotherapy . LABORATORY INVESTIGATION . vol. 100 , 1024 - 1024 .
Gaba F, Chandrasekaran D, Menon U, Evans G, Singh N, McCluggage G, Wilkinson N, Ganesan R et al. ( 2019 ) . EP1229 Preventing ovarian cancer through early excision of tubes and late ovarian removal (PROTECTOR) study . International Journal of Gynecological Cancer . Conference: ePoster Talks: Ovarian + Endometria vol. 29 ,
Gaba F, Liu X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Menon U, Jacobs I et al. ( 2019 ) . EP1231 Impact of population genetic testing and ovarian cancer risk stratification on the emotional well-being and health of unselected women in a general population . International Journal of Gynecological Cancer . Conference: ePoster Talks: Ovarian + Endometria vol. 29 ,
Sundar S, Cummins C, Kumar S, Long J, Arora V, Balega J, Broadhead T, Duncan T et al. ( 2019 ) . EP1269 Quality of life after surgery of varying surgical complexity in advanced ovarian cancer: results from the international, prospective, multicenter cohort SOCQER2 study . International Journal of Gynecological Cancer . Conference: ePoster vol. 29 ,
Daia M, Chandrasekaran D, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A, Phadnis S ( 2019 ) . EP1332 Follow the yellow brick road – Supra-renal para-aortic lymphadenectomy for metastatic ovarian cancer . International Journal of Gynecological Cancer . Conference: Cinema Viewing vol. 29 ,
Gaba F, Farrag A, Lawrence A, Brockbank E, Jeyarajah A, Manchanda R, Phadnis S ( 2019 ) . EP1342 Ovarian cancer with metastatic inguinal lymphadenopathy: an abdominal approach to inguinal nodes dissection . International Journal of Gynecological Cancer . Conference: Cinema Viewing vol. 29 ,
Dokmeci A, Abdurrayman M, Drymiotou S, Chandrasekaran D, Rai N, Dilley J, Phadnis S, Manchanda R et al. ( 2019 ) . EP507 Has the robot been beneficial to endometrial cancer patients? A prospective quality improvement project at a london gynae-oncology tertiary centre . International Journal of Gynecological Cancer . Conference: ePoster vol. 29 ,
Drymiotou S, Dokmeci A, Chandrasekaran D, Dilley J, Rai N, Lawrence A, Manchanda R, Phadnis S et al. ( 2019 ) . EP510 Robotic surgery: does high body mass index (BMI) matter? . International Journal of Gynecological Cancer . Conference: ePoster vol. 29 ,
Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al. ( 2019 ) . Randomised trial of unselected BRCA testing in ashkenazi jews: long term outcomes and factors affecting uptake of testing . International Journal of Gynecological Cancer . Conference: Best Oral/Late-Breaking Abstracts 4 – Miscellaneous vol. 29 ,
Sun L, Brentnall A, Patel S, Buist D, Bowles E, Evans D, Eccles D, Hopper J et al. ( 2019 ) . Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis . International Journal of Gynecological Cancer . Conference: Oral Communication 4 – Gynaecological Cancer vol. 29 ,
Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J et al. ( 2019 ) . A Cost-effectiveness Analysis of Multigene Testing for All Patients with Breast Cancer . JAMA Oncology
Manchanda R, Sun L, Patel S, Wilschut J, de Freitas ALC, Brentnall A, Duffy S, Cui B et al. ( 2019 ) . 10 Global economic evaluation of population-based BRCA1/BRCA2 mutation testing . International Journal of Gynecological Cancer . Conference: Plenary sessions vol. 29 ,
Sun L, Brentnall A, Patel S, Buist SM D, Bowles JA E, Evans R DG, Eccles D, Hopper J et al. ( 2019 ) . 66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis . Regional plenaryA36.2 - A37 .
Manchanda R, Burnell M, Gaba F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al. ( 2019 ) . 81 Attitude towards and factors affecting uptake of population based BRCA testing in ashkenazi jews: a cohort study . International Journal of Gynecological Cancer . Conference: E-Poster discussions vol. 29 ,
Manchanda R, Burnell M, Gaba F, Desai R, Wardle J, Gessler S, Side L, Sanderson S et al. ( 2019 ) . Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term outcomes . BJOG An International Journal of Obstetrics & Gynaecology vol. 127 , ( 3 ) 364 - 375 .
Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I et al. ( 2019 ) . Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results . Histopathology vol. 75 , ( 6 ) 813 - 824 .
Tan A, Rivas C, Yorke S, Khan K, Rogozinska E, Brockbank E, Manchanda R, Cooper N ( 2019 ) . Variation in the outcome reported by studies of interventions for atypical endometrial hyperplasia: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets) . BJOG: an International Journal of Obstetrics and Gynaecology . Conference: RCOG World Congress 2019 vol. 126 , 85 - 85 .
Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al. ( 2019 ) . Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data . Gynecologic Oncology
Cohen P, Powell A, B&ouml;hm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S et al. ( 2019 ) . Pathological Chemotherapy Response Score Predicts Survival in Patients with Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis of Individual Patient Data . Gynecologic Oncology
Crosbie E, MANCHANDA R, Manchester International Consensus Group ( 2019 ) . The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome . Genetics in Medicine
GABA F, Piek J, Menon U, MANCHANDA R ( 2019 ) . Risk reducing early salpingectomy and delayed oophorectomy as a two staged alternative for primary prevention of ovarian cancer in increased risk women: a commentary . BJOG: An International Journal of Obstetrics and Gynaecology
MANCHANDA R, GABA F ( 2019 ) . A commentary on population genetic testing for primary prevention: changing landscape and the need to change paradigm . BJOG: An International Journal of Obstetrics and Gynaecology
Koutoukidis D, Beeken R, MANCHANDA R, Burnell M, Ziauddeen N, Michalopoulou M, Knobf MT, Lanceley A ( 2019 ) . Diet, physical activity, and health-related outcomes of endometrial cancer survivors in a behavioural lifestyle programme: the Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised controlled pilot trial . International Journal of Gynecological Cancer vol. 29 , ( 3 )
MANCHANDA R, Matthew B, GABA F, Sanderson S, Loggenberg K, Gessler S, Wardle J, Side L et al. ( 2019 ) . Attitude towards and factors affecting uptake of population based BRCA testing in the Ashkenazi Jewish population: a cohort study . BJOG: An International Journal of Obstetrics and Gynaecology
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N ( 2019 ) . Key patient outcomes on studies managing atypical endometrial hyperplasia and endometrial cancer: two sets of patient workshops and semi-structured interviews (the second step in the development of CRUK-funded Core Outcome Sets) . BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY . vol. 126 , 82 - 82 .
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N ( 2019 ) . Variation in the outcome reported by studies of fertility-sparing interventions for atypical endometrial hyperplasia and early endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets) . BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY . vol. 126 , 84 - 84 .
Tan A, Rivas C, Yorke S, Khan K, Brockbank E, Manchanda R, Cooper N ( 2019 ) . Variation in the outcome reported by studies of interventions for endometrial cancer: a systematic review (the first step in the development of CRUK-funded Core Outcome Sets) . BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY . vol. 126 , 86 - 87 .
Osman M, Chandrasekaran D, Musa E, Afnan-Holmes H, Brockbank E, Lawrence A, Manchanda R ( 2018 ) . Evaluation of the diagnostic hysteroscopy service in gynaecology oncology . BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY . Conference: National Trainees Conference 2018 vol. 125 , 24 - 24 .
MANCHANDA R, GABA F ( 2018 ) . Population Based Testing for Primary Prevention: A Systematic Review . Cancers
Puntambekar S, MANCHANDA R ( 2018 ) . Surgical pelvic anatomy in gynecologic oncology . International Journal of Gynecology and Obstetrics vol. 143 , 86 - 92 .
Manchanda R, Gaba F ( 2018 ) . Population Based Testing for Primary Prevention: A Systematic Review .
MANCHANDA R, Legood R ( 2018 ) . Population based germline testing for primary cancer prevention . Oncotarget vol. 9 , ( 69 ) 33062 - 33063 .
Vazquez MA, Marino IP, BLYUSS O, Ryan A, GENTRY-MAHARAJ A, Kalsi J, MANCHANDA R, Jacobs I et al. ( 2018 ) . A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer . Biomedical Signal Processing and Control
BLYUSS O, Burnell M, Ryan A, GENTRY-MAHARAJ A, Marino I, Kalsi J, MANCHANDA R, Timms JF et al. ( 2018 ) . Comparison of longitudinal CA125 algorithms as a first line screen for ovarian cancer in the general population . Clinical Cancer Research
Chuang L, Berek J, Randall T, McCormack M, Schmeler K, Manchanda R, Rebbeck T, Jeng CJ et al. ( 2018 ) . Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities . Gynecologic Oncology Reports
Mariño IP, Vázquez MA, Blyuss O, Ryan A, Gentry-Maharaj A, Kalsi J, Manchanda R, Jacobs I et al. ( 2018 ) . Diagnosis of ovarian cancer based on longitudinal measurements of multiple biomarkers . Opera Medica et Physiologica vol. 4 , 71 - 72 .
Crusz SM, Chandrasekaran D, Phadnis S, Delvin MJ, Quigley M, Powell ME, Jeyarajah A, Oram D et al. ( 2018 ) . Outcome of patients undergoing delayed debulking surgery (DDS) in advanced ovarian cancer (OC) . Journal of Clinical Oncology . vol. 36 , e17530 - e17530 .
Chandrasekaran D, Manchanda R ( 2018 ) . Germline & somatic genetic testing in ovarian cancer patients . BJOG
Yang X, Leslie G, Gentry-Maharaj A, Ryan A, Intermaggio M, Lee A, Kalsi JK, Tyrer J et al. ( 2018 ) . Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study . Journal of Medical Genetics vol. 55 , ( 8 )
Chandrasekaran D, Gaba F, Manchanda R ( 2018 ) . Preinvasive Disease, Screening and Hereditary Cancer . Gynaecological Oncology for the MRCOG , Cambridge University Press (CUP)
Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Gan C, Taylor R et al. ( 2018 ) . Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population . Journal of Medical Genetics vol. 55 , ( 8 )
Manchanda R, Patel S, Gordeev VS, Antoniou AC, Smith S, Lee A, Hopper JL, MacInnis RJ et al. ( 2018 ) . Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women . Journal of the National Cancer Institute vol. 110 , ( 7 ) 714 - 725 .
Jiang J, Phadnis S, Miller R, Powell M, Sahdev A, Singh N, Lawrence A, Brockbank E et al. ( 2018 ) . DISTANT RECURRENCES ARE COMMON FOLLOWING PELVIC EXENTERATION FOR MALIGNANCY OF NON-CERVICAL ORIGIN . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 28 , 963 - 963 .
Jiang J, Phadnis S, Miller R, Lawrence A, Brockbank E, Manchanda R, Jeyarajah A ( 2018 ) . OUTCOMES OF BOWEL RESECTIONS DURING SURGICAL CYTOREDUCTION OF ADVANCED STAGE OVARIAN CANCER: SHOULD WE BE WORKING TOWARDS REDUCING STOMA RATES? . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 28 , 719 - 719 .
Singh N, Piskorz A, Bosse T, Jimenez-Linan M, Jeyarajah A, Manchanda R, Gilks CB, Brenton J et al. ( 2018 ) . P53 IMMUNOHISTOCHEMISTRY AS A SURROGATE FOR TP53 MUTATIONAL ANALYSIS IN ENDOMETRIAL CANCER BIOPSIES . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 28 , 565 - 565 .
Sundar S, Kumar S, Long J, Balega J, Fotopoulou C, Broadhead T, Duncan T, Morrison J et al. ( 2018 ) . PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 28 , 604 - 606 .
Farrag A, Light M, Sahdev A, Singh N, Brockbank E, Manchanda R, Phadnis S ( 2018 ) . SOLITARY RECURRENCE OF SQUAMOUS CELL CARCINOMA OF THE CERVIX IN THE OMENTUM - MANAGEMENT OF AN UNUSUAL PRESENTATION . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 28 , 366 - 366 .
Patel S, Legood R, Evans DG, Turnbull C, Antoniou AC, Menon U, Jacobs I, Manchanda R ( 2017 ) . Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women . American Journal of Obstetrics and Gynecology vol. 218 , ( 4 ) 431.e1 - 431.e12 .
MANCHANDA R, Menon U ( 2017 ) . Setting the threshold for surgical prevention in women at increased risk of ovarian cancer . International Journal of Gynecological Cancer
Meisel SF, Freeman M, Waller J, Fraser L, Gessler S, Jacobs I, Kalsi J, Rahman B et al. ( 2017 ) . Impact of a decision aid about stratified ovarian cancer risk-management on women’s knowledge and intentions: a randomised online experimental survey study . BMC Public Health vol. 17 , Article 882 ,
Koutoukidis DA, Beeken RJ, Manchanda R, Michalopoulou M, Burnell M, Knobf MT, Lanceley A ( 2017 ) . Recruitment, adherence, and retention of endometrial cancer survivors in a behavioural lifestyle programme: The Diet and Exercise in Uterine Cancer Survivors (DEUS) parallel randomised pilot trial . BMJ Open vol. 7 , ( 10 )
Manchanda R, Patel S, Antoniou AC, Levy-Lahad E, Turnbull C, Evans DG, Hopper JL, Macinnis RJ et al. ( 2017 ) . Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry . American Journal of Obstetrics and Gynecology vol. 217 , ( 5 ) 578.e1 - 578.e12 .
Gan C, Chenoy R, Chandrasekaran D, Brockbank E, Hollingworth A, Vimplis S, Lawrence AC, Jeyarajah AR et al. ( 2017 ) . Persistence of fimbrial tissue on the ovarian surface after salpingectomy . American Journal of Obstetrics and Gynecology vol. 217 , ( 4 ) 425.e1 - 425.e16 .
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al. ( 2017 ) . Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study . Obstetrical & Gynecological Survey vol. 72 , ( 6 ) 338 - 340 .
Bansal JK, Goldrick IG, Manchanda R, Olaitan A ( 2017 ) . Rapid-access gynecological oncology clinic outcomes in North London, UK . Clinical Audit vol. 9 , 19 - 23 .
MANCHANDA R, Legood R, Antoniou AC, Pearce L, Menon U ( 2017 ) . Changing the Risk Threshold for Surgical Prevention of Ovarian Cancer . BJOG: An International Journal of Obstetrics and Gynaecology
Rosenthal AN, Fraser LSM, Philpott S, Manchanda R, Burnell M, Badman P, Hadwin R, Rizzuto I et al. ( 2017 ) . Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study . J Clin Oncol vol. 35 , ( 13 ) 1411 - 1420 .
Johnston C, Ng JS, Manchanda R, Tsunoda AT, Chuang L ( 2017 ) . Variations in gynecologic oncology training in low (LIC) and middle income (MIC) countries (LMICs): Common efforts and challenges . Gynecologic Oncology Reports vol. 20 , 9 - 14 .
Manchanda R ( 2017 ) . Opportunistic salpingectomy for prevention of ovarian cancer . BJOG: An International Journal of Obstetrics and Gynaecology vol. 124 , ( 6 ) 890 - 890 .
Gan C, Bossart M, Piek J, Halaska M, Haidopoulos D, Zapardiel I, Grabowski JP, Kesic V et al. ( 2017 ) . Robotic and Advanced Laparoscopic Surgical Training in European Gynecological Oncology Trainees . International Journal of Gynecological Cancer vol. 27 , ( 2 ) 375 - 381 .
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A ( 2017 ) . Erratum: Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: Study protocol for a randomized controlled trial. [Trials. (2016), 17, (130)], DOI: 10.1186/s13063-016-1260-1 . Trials vol. 18 , ( 1 ) 28 - 28 .
Gaba FM, Manchanda R, Gaba FM, Manchanda R ( 2017 ) . Genetic testing for gynaecological cancer . Obstetrics, Gynaecology and Reproductive Medicine vol. 27 , ( 1 ) 29 - 31 .
Manchanda R, Gaba F, Bottla K, Mousa K, Burnell M, Kalsi J, Gentry-Maharaj A, Antoniou A et al. ( 2017 ) . PREDICTING RISK OF OVARIAN MALIGNANCY IMPROVED SCREENING AND EARLY DETECTION FEASIBILITY STUDY (PROMISE-FS) . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 27 , 1944 - 1944 .
Pennington M, Gentry-Maharaj A, Karpinskyj C, Miners A, Taylor J, Manchanda R, Iyer R, Griffin M et al. ( 2016 ) . Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) . PLoS One vol. 11 , ( 11 ) Article 0165539 , e0165539 - e0165539 .
La Russa M, Biliatis I, Brockbank E, Faruki A, Lawrence A, Manchanda R, Singh N, Jeyarajah A ( 2016 ) . CONSERVATIVE TREATMENT FOR FERTILITY SPARING IN YOUNG WOMEN WITH ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA. RESULTS FROM A ON GOING PROSPECTIVE SINGLE CENTRE STUDY . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting ( Lisbon, Portugal ) from: 29/10/2016 to: 31/10/2016 , vol. 26 , 1013 - 1013 .
Manchanda R, Gordeev V, Antoniou A, Smith S, Lee A, Hopper J, Macinnis R, Paul P et al. ( 2016 ) . Cost-effectiveness of systematic population based screening for BRCA1, BRCA2, RAD51C, RAD51D and BRIP1 gene mutations in unselected general population women . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . Conference: 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016) vol. 26 , 59 - 60 .
Kumar S, Long J, Rudge G, Manchanda R, Fotopoulou C, Wood N, Duncan T, Balega J et al. ( 2016 ) . SOCQER-2 Study: Preliminary analysis of multicentre recruitment after surgery in advanced ovarian cancer . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . Conference: 16th biennial International Gynecologic Cancer Society (IGCS) meeting, Lisbon, Portugal ( Lisbon, Portugal ) from: 29/10/2016 to: 31/10/2016 , vol. 26 , 832 - 833 .
Chuang LT, Randall TC, Denny L, Johnston CM, Schmeler KM, Covens AL, Cibula D, Bookman MA et al. ( 2016 ) . Sister Society Meeting on Global Education Development and Collaboration: Meeting Report . International Journal of Gynecological Cancer vol. 26 , ( 6 ) 1186 - 1188 .
Manchanda R, Legood R, Antoniou AC, Gordeev VS, Menon U ( 2016 ) . Specifying the ovarian cancer risk threshold of ‘premenopausal risk-reducing salpingo-oophorectomy’ for ovarian cancer prevention: a cost-effectiveness analysis . Journal of Medical Genetics vol. 53 , ( 9 )
Manchanda R, Cibula D ( 2016 ) . Ovarian Cancer Screening There May Be Light at the End of the Tunnel? . Int J Gynecol Cancer vol. 26 , ( 4 ) 608 - 609 .
Burnell M, Iyer R, Gentry‐Maharaj A, Nordin A, Liston R, Manchanda R, Das N, Gornall R et al. ( 2016 ) . Benchmarking of surgical complications in gynaecological oncology: prospective multicentre study . BJOG An International Journal of Obstetrics & Gynaecology vol. 123 , ( 13 ) 2171 - 2180 .
Manchanda R, Burnell M, Loggenberg K, Desai R, Wardle J, Sanderson SC, Gessler S, Side L et al. ( 2016 ) . Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutations . Journal of Medical Genetics vol. 53 , ( 7 )
Koutoukidis DA, Beeken RJ, Manchanda R, Burnell M, Knobf MT, Lanceley A ( 2016 ) . Diet and exercise in uterine cancer survivors (DEUS pilot) - piloting a healthy eating and physical activity program: study protocol for a randomized controlled trial . Trials vol. 17 , ( 1 )
MANCHANDA R, Menon U ( 2016 ) . Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial FOR: There is lack of clarity on a number of key issues . BJOG: an International Journal of Obstetrics and Gynaecology vol. 123 , ( 3 ) 463 - 463 .
Phadnis S, Vali S, Oram D, Lawrence A, Manchanda R, Jeyarajah A, Brockbank E ( 2016 ) . Enhanced recovery after major gynaecological oncology surgery: Are we meeting the standards? . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 26 , 924 - 924 .
Phadnis S, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E ( 2016 ) . Morbidity and mortality following major surgery for gynaecological malignancy: A prospective observational study from a cancer centre in London . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 26 , 925 - 925 .
Manchanda R, Chandrasekaran D, Saridogan E, Burnell M, Crawford R, Brockbank E, Kalsi J, Jurkovic D et al. ( 2016 ) . Should Opportunistic Bilateral Salpingectomy (OBS) for Prevention of Ovarian Cancer Be Incorporated Into Routine Care or Offered in the Context of a Clinical Trial? . International Journal of Gynecological Cancer vol. 26 , ( 1 )
Manchanda R, Legood R, Antoniou A, Gordeev V, Menon U ( 2016 ) . Specifying the threshold of 'ovarian cancer risk' for undertaking risk reducing surgery for ovarian cancer prevention in premenopausal women . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 26 , 767 - 767 .
Phadnis S, Korompelis P, Iamprou C, Lawrence A, Oram D, Manchanda R, Jeyarajah A, Brockbank E ( 2016 ) . Surgical and oncological outcome of morbidly obese (BMI &gt; 40) women having laparoscopic surgery for early stage endometrial cancer . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 26 , 1057 - 1057 .
Blyuss KB, MANCHANDA R, Kurths J, Alsaedi A, Zaikin A ( 2016 ) . Systems Medicine of Cancer: Bringing Together Clinical Data and Nonlinear Dynamics of Genetic Networks . Computational and Mathematical Methods in Medicine vol. 2016 , Article 7904693 ,
Dilley J, Manchanda R, Johnson M, Rosenthal AN, Gessler S, Menon U ( 2015 ) . Importance of serial CA125 measurements over an absolute cut-off value for the detection of asymptomatic ovarian cancer in high-risk patients . International Journal of Gynecology & Obstetrics vol. 133 , ( 2 ) 239 - 240 .
Manchanda R, Jacobs I ( 2015 ) . Genetic screening for gynecological cancer: where are we heading? . Future Oncology vol. 12 , ( 2 ) 207 - 220 .
Manchanda R, Legood R, Pearce L, Menon U ( 2015 ) . Defining the risk threshold for risk reducing salpingo-oophorectomy for ovarian cancer prevention in low risk postmenopausal women . Gynecologic Oncology vol. 139 , ( 3 ) 487 - 494 .
Manchanda R ( 2015 ) . Abstract IS01: Brca testing in high-risk populations . Clinical Cancer Research . vol. 21 , is01 - is01 .
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al. ( 2015 ) . Risk Reducing Salpingectomy and Delayed Oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK . Familial Cancer vol. 14 , ( 4 ) 521 - 530 .
Chandrasekaran D, Menon U, Evans G, Crawford R, Saridogan E, Jacobs C, Tischkowitz M, Brockbank E et al. ( 2015 ) . Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK . Familial Cancer vol. 14 , ( 4 ) 521 - 530 .
Jervis S, Song H, Lee A, Dicks E, Harrington P, Baynes C, Manchanda R, Easton DF et al. ( 2015 ) . A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects . Journal of Medical Genetics vol. 52 , ( 7 )
Manchanda R, Refaie A ( 2015 ) . Acute pneumoperitoneum following coitus . Canadian Journal of Emergency Medicine vol. 7 , ( 1 ) 51 - 53 .
Manchanda R, Loggenberg K, Burnell M, Wardle J, Sanderson S, Gessler S, Side L, Balogun N et al. ( 2015 ) . A NON-INFERIORITY CLUSTER RANDOMISED TRIAL COMPARING TRADITIONAL FACE-TO-FACE AND DVD-BASED GENETIC COUNSELLING IN SYSTEMATIC POPULATION BASED BRCA1/2 TESTING . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 25 , 48 - 49 .
Manchanda R, Legood R, Pearce L, Menon U ( 2015 ) . DEFINING THE RISK THRESHOLD FOR RISK REDUCING SALPINGO-OOPHORECTOMY FOR OVARIAN CANCER PREVENTION IN LOW RISK POSTMENOPAUSAL WOMEN . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 25 , 600 - 601 .
Karpinskyj CL, Taylor J, Lewis D, Keller C, Pennington M, Ryan A, Manchanda R, Iyer R et al. ( 2015 ) . QUALITY OF LIFE IN ENDOMETRIAL CANCER SURVIVORS - A COHORT STUDY NESTED WITHIN THE UNITED KINGDOM COLLABORATIVE TRIAL OF OVARIAN CANCER SCREENING (UKCTOCS) . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 25 , 610 - 611 .
Piek J, Bossart M, Boor K, Halaska M, Haidopoulos D, Zapardiel I, Grabowski J, Kesic V et al. ( 2015 ) . The Work Place Educational Climate in Gynecological Oncology Fellowships Across Europe . International Journal of Gynecological Cancer vol. 25 , ( 1 ) 180 - 190 .
Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, Das N, Desai R et al. ( 2014 ) . Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC—UK gynaecological oncology surgical outcomes and complications) . British Journal of Cancer vol. 112 , ( 3 ) 475 - 484 .
Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S et al. ( 2014 ) . Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing . Journal of the National Cancer Institute vol. 107 , ( 1 )
Manchanda R, Loggenberg K, Sanderson S, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al. ( 2014 ) . Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial . Journal of the National Cancer Institute vol. 107 , ( 1 )
Manchanda R, Menon U ( 2014 ) . Serum markers for gynaecological cancer in the reproductive years . Cancer and Reproductive Health , Cambridge University Press (CUP)
Kalsi JK, Manchanda R, Menon U ( 2014 ) . Screening for gynecological cancers . Expert Review of Obstetrics & Gynecology vol. 8 , ( 2 ) 143 - 160 .
Manchanda R, Sanderson S, Loggenberg K, Burnell M, Wardle J, Gessler S, Side L, Balogun N et al. ( 2014 ) . POPULATION PREVALENCE OF UK ASHKENAZI BRCA-MUTATIONS, PERFORMANCE OF AND ESTIMATED TIME-TO, FAMILY-HISTORY BASED IDENTIFICATION OF ALL BRCA CARRIERS . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 24 , 30 - 31 .
Manchanda R, Legood R, Burnell M, McGuire A, Loggenberg K, Wardle J, Sanderson S, Gessler S et al. ( 2014 ) . POPULATION-BASED TESTING FOR BRCA MUTATIONS (COMPARED TO FAMILY-HISTORY BASED TESTING) MAY BE COST SAVING IN ASHKENAZI-JEWS: A HEALTH-ECONOMICS DECISION ANALYTICAL MODEL . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 24 , ( 9 ) 470 - 471 .
Manchanda R, Gessler S, Loggenberg K, Sanderson S, Burnell M, Wardle J, Side L, Balogun N et al. ( 2014 ) . Population Testing for Inherited, Cancer Predisposing BRCA 1 and BRCA2 Founder Mutations in the Ashkenazi Jewish Community in London: The Psychological Impact on Participants of a Randomised Controlled Trial . PSYCHO-ONCOLOGY . vol. 23 , 120 - 121 .
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al. ( 2013 ) . Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2) . Journal of Clinical Oncology vol. 31 , ( 15_suppl ) 5507 - 5507 .
Manchanda R, Halaska MJ, Piek JM, Grabowski JP, Haidopoulos D, Zapardiel I, Gultekin M, Vranes B et al. ( 2013 ) . The Need for More Workshops in Laparoscopic Surgery and Surgical Anatomy for European Gynaecological Oncology Trainees: A Survey by the European Network of Young Gynaecological Oncologists . International Journal of Gynecological Cancer vol. 23 , ( 6 )
Philpott S, Rizzuto I, Fraser L, Manchanda R, Hadwin R, Burnell M, Mackay S, Skates S et al. ( 2013 ) . DETECTION OF NON-OVARIAN CANCERS ON PHASE 2 OF THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UKFOCSS) . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23 , ( 8 )
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al. ( 2013 ) . Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2) . JOURNAL OF CLINICAL ONCOLOGY . vol. 31 ,
Manchanda R, Legood R, Burnell M, McGuire A, Legood R, Loggenberg K, Wardle J, Sanderson S et al. ( 2013 ) . POPULATION BASED TESTING FOR BRCA MUTATIONS IS HIGHLY COST-EFFECTIVE COMPARED TO FAMILY HISTORY BASED APPROACH: A HEALTH-ECONOMIC DECISION ANALYTICAL MODEL FROM THE GCAPPS TRIAL . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 23 ,
Rosenthal AN, Fraser L, Philpott S, Manchanda R, Badman P, Hadwin R, Evans DG, Eccles D et al. ( 2013 ) . RESULTS OF INTENSIVE ALGORITHM-BASED SCREENING IN THE UK FAMILIAL OVARIAN CANCER SCREENING STUDY (UK FOCSS PHASE 2) . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER vol. 23 , ( 8 )
Rosenthal AN, Fraser L, Manchanda R, Badman P, Philpott S, Mozersky J, Hadwin R, Cafferty FH et al. ( 2012 ) . Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule . Journal of Clinical Oncology vol. 31 , ( 1 ) 49 - 57 .
Manchanda R, Godfrey M, Wong-Taylor LA, Halaska MJ, Burnell M, Grabowski JP, Gultekin M, Haidopoulos D et al. ( 2012 ) . The need for accredited training in gynaecological oncology: a report from the European Network of Young Gynaecological Oncologists (ENYGO) . Annals of Oncology vol. 24 , ( 4 ) 944 - 952 .
Manchanda R, Drapkin R, Menon U ( 2012 ) . There is a need for routine peritoneal cytology at RRSO . Gynecologic Oncology vol. 128 , ( 1 ) 149 - 150 .
Manchanda R, Saridogan E, Abdelraheim A, Johnson M, Rosenthal AN, Benjamin E, Brunell C, Side L et al. ( 2012 ) . Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS) . Archives of Gynecology and Obstetrics vol. 286 , ( 6 ) 1555 - 1562 .
Brantnerova R, Manchanda R, Colombo N ( 2012 ) . The European Society of Gynaecological Oncology: Update on Objectives and Educational and Research Activities . American Society of Clinical Oncology Educational Book ( 32 ) 335 - 338 .
Fourkala EO, Gentry-Maharaj A, Burnell M, Ryan A, Manchanda R, Dawnay A, Jacobs I, Widschwendter M et al. ( 2012 ) . Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening . British Journal of Cancer vol. 106 , ( 12 ) 1910 - 1916 .
Menon U, Kalsi J, Jacobs I, Manchanda R, Beller U, Mould T, Skates S, Lokshin A ( 2012 ) . International Conference on Ovarian Cancer Screening . International Journal of Gynecological Cancer vol. 22 , ( &NA; )
Gentry-Maharaj A, Kalsi J, Burnell M, Manchanda R, Menon U ( 2012 ) . Screening of symptomatic women for ovarian cancer . The Lancet Oncology vol. 13 , ( 4 ) e138 - e139 .
Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E et al. ( 2012 ) . Factors influencing uptake and timing of risk reducing salpingo‐oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis . BJOG An International Journal of Obstetrics & Gynaecology vol. 119 , ( 5 ) 527 - 536 .
Manchanda R, Silvanto A, Abdelraheim A, Burnell M, Johnson M, Saridogan E, Rosenthal AN, Brunell C et al. ( 2012 ) . Diathermy-Induced Injury May Affect Detection of Occult Tubal Lesions at Risk-Reducing Salpingo-Oophorectomy . International Journal of Gynecological Cancer vol. 22 , ( 5 )
Manchanda R, Loggenberg K, Gessler S, Sanderson S, Balogun N, Wardle J, Tomlinson I, McGuire A et al. ( 2012 ) . Population based testing for high-penetrance dominant gene mutations: initial results from the pilot phase of GCaPPS . INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER . vol. 22 , S42 - S43 .
Vaes E, Manchanda R, Autier P, Nir R, Nir D, Bleiberg H, Robert A, Menon U ( 2011 ) . Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer‐aided diagnostic tool . Ultrasound in Obstetrics and Gynecology vol. 39 , ( 1 ) 91 - 98 .
Manchanda R, Drapkin R, Jacobs I, Menon U ( 2011 ) . The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer . Gynecologic Oncology vol. 124 , ( 2 ) 185 - 191 .
( 2011 ) . Cross-sectional imaging . An Atlas of Gynecologic Oncology , Taylor & Francis
Gultekin M, Dursun P, Vranes B, Laky R, Bossart M, Grabowski JP, Piek JMJ, Manchanda R et al. ( 2011 ) . Gynecologic Oncology Training Systems in Europe: A Report From the European Network of Young Gynaecological Oncologists . International Journal of Gynecological Cancer vol. 21 , ( 8 )
Manchanda R, Abdelraheim A, Johnson M, Rosenthal A, Benjamin E, Brunell C, Burnell M, Side L et al. ( 2011 ) . Outcome of risk‐reducing salpingo‐oophorectomy in BRCA carriers and women of unknown mutation status . BJOG An International Journal of Obstetrics & Gynaecology vol. 118 , ( 7 ) 814 - 824 .
Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Autier P, Menon U, Robert A ( 2011 ) . Mathematical Models to Discriminate Between Benign and Malignant Adnexal Masses . International Journal of Gynecological Cancer vol. 21 , ( 1 ) 35 - 43 .
Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, Ryan A, Seif MW et al. ( 2010 ) . Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort . The Lancet Oncology vol. 12 , ( 1 ) 38 - 48 .
Shafi MI, Earl HM, Tan LT, Manchanda R, Jacobs IJ ( 2010 ) . Screening and prevention of gynaecological cancers . Gynaecological Oncology , Cambridge University Press (CUP)
Pichert G, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al. ( 2010 ) . Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers . Familial Cancer vol. 9 , ( 3 ) 313 - 319 .
Izatt L, Jacobs C, Jacobs I, Menon U, Manchanda R, Johnson M, Hamed H, Firth C et al. ( 2010 ) . Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers . JOURNAL OF MEDICAL GENETICS . vol. 47 , S116 - S116 .
Vaes E, Manchanda R, Nir R, Nir D, Bleiberg H, Robert A, Menon U ( 2009 ) . 1329 A sequential use of the Risk of Malignancy Index and Ovarian HistoScanning for the differential diagnosis of adnexal masses . European Journal of Cancer Supplements vol. 7 , ( 2 )
Manchanda R, Sriemevan A ( 2009 ) . Anaphylactoid syndrome caused by amniotic fluid embolism following manual removal of placenta . Journal of Obstetrics and Gynaecology vol. 25 , ( 2 ) 201 - 202 .
Manchanda R, Palep-singh M, Prentice A ( 2009 ) . Can uterine artery embolisation affect endometrial perfusion and function . Journal of Obstetrics and Gynaecology vol. 28 , ( 2 ) 246 - 248 .
Manchanda R, Rosenthal A, Burnell M, Fraser L, Mackay J, Skates S ( 2009 ) . Change in stage distribution observed with annual screening for ovarian cancer in BRCA carriers . Journal of Medical Genetics vol. 46 , ( 6 )
Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I ( 2009 ) . Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective . Current Opinion in Obstetrics & Gynecology vol. 21 , ( 1 ) 31 - 38 .
Manchanda R, Baldwin P, Crawford R, Vowler S, Moseley R, Latimer J, Welton K, Shafi M ( 2008 ) . Is close follow up feasible for high‐risk cervical premalignant lesion in developing countries? . BJOG An International Journal of Obstetrics & Gynaecology vol. 116 , ( 1 ) 125 - 126 .
Kriplani A, Agarwal N, Parul, Sharma MC, Manchanda R ( 2008 ) . Bilateral seminomas in a 45X/46XY mosaic with Turner's phenotype: An unusual case of mixed gonadal dysgenesis . Journal of Obstetrics and Gynaecology Research vol. 29 , ( 2 ) 63 - 66 .
Manchanda R, Baldwin P, Crawford R, Vowler S, Moseley R, Latimer J, Welton K, Shafi M ( 2008 ) . Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years . BJOG An International Journal of Obstetrics & Gynaecology vol. 115 , ( 10 ) 1238 - 1242 .
MANCHANDA R, KRIPLANI A ( 2005 ) . Giant malignant ovarian tumor: a case report . International Journal of Gynecological Cancer vol. 15 , ( 6 ) 1135 - 1137 .
Manchanda R, Varma R, Anya I, Ting JYS ( 2004 ) . Representation of authors and editors from poor countries [1] (multiple letters) . British Medical Journal vol. 329 , ( 7457 ) 110 - 111 .
Manchanda R, Varma R ( 2004 ) . Representation of authors and editors from poor countries: Observed publication bias may reflect who is funding research . The BMJ vol. 329 , ( 7457 )
Kriplani A, Manchanda R, Nath J, Takkar D ( 2002 ) . A randomized trial of danazol pretreatment prior to endometrial resection . European Journal of Obstetrics & Gynecology and Reproductive Biology vol. 103 , ( 1 ) 68 - 71 .
Kriplani A, Manchanda R, Agarwal N, Nayar B ( 2001 ) . Laparoscopic Ovarian Drilling in Clomiphene Citrate-Resistant Women with Polycystic Ovary Syndrome . Journal of Minimally Invasive Gynecology vol. 8 , ( 4 ) 511 - 518 .
Kriplani A, Manchanda R, Monga D, Takkar D ( 2001 ) . Depot Medroxy Progesterone Acetate: A Poor Preparatory Agent for Endometrial Resection . Gynecologic and Obstetric Investigation vol. 52 , ( 3 ) 180 - 183 .
Kriplani A, Agarwal N, Roy KK, Manchanda R, Singh MK ( 2001 ) . Laparoscopic management of Sertoli-Leydig cell tumors of the ovary. A report of two cases . The Journal of Reproductive Medicine vol. 46 , ( 5 ) 493 - 496 .
Back to Search